COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients
Washington: A new study has revealed a previously unknown interaction between two cornerstone Parkinson’s disease medications that could unintentionally reduce treatment effectiveness in some patients. Researchers at Yale School of…
FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development
Washington: On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…















